It was previously demonstrated that Src inhibition reduced microglial activation and subsequent inflammation, resulting in greater numbers of dopaminergic neurons and improved behavior in a mouse model of PD (Tai et al., 2013). This evidence concerns the gene SRC and Parkinson disease.